Problem Tech Solves

Just because patients have their medications doesn’t mean they’re taking them correctly or even at all. But nearly all of the medication adherence solutions on the market today focus on indirect measures of adherence that measure whether a person has picked up or possesses their medications, and they completely miss the mark. This is why medication adherence is still a massive, $500B problem leading to more than 125,000 deaths yearly. But it doesn’t have to be this way. Directly Observed Therapy (DOT), a strategy that involves watching a patient take every dose of medication, is a validated public health model of care that has been used for over 50 years and is considered the gold standard for true medication adherence. The problem with DOT is that it’s hard to implement and scale due to limitations related to provider shortages, lack of patient transportation, and other issues. But by harnessing the power of video-based DOT, emocha alleviates all of the pain points of DOT and makes the model feasible, scalable, and efficient. With emocha, patients can receive the personalized care of DOT over video communication anytime and anywhere. emocha’s platform and model are responsible for significant improvements in adherence rates, engagement scores, and health outcomes for vulnerable, hard-to-reach patients across a spectrum of chronic and infectious diseases, including tuberculosis, diabetes, asthma, and hypertension. We believe that a digital health revolution requires true adherence measures that are value-based and outcomes relevant, and we’re leading the way in championing that revolution.